Thursday, August 28, 2008 Free Registration Log-in to View Profiles
Empire Relations Group is a Premier Investor Relations Organization representing publicly-traded companies in their communications programs with existing shareholders and potential investors.
investments
OTCBB
OTCBB
Pressroom 
 
 Archived
 
 Non-Public Companies
 Consumer
 Energy, Environment & Natural Resources
 Financials
 Healthcare/BioTech
 Industrials
 IT & Computers
 Materials
 Telecommunications
 Utilities
 
 Public Companies
 Consumer
 Energy, Environment & Natural Resources
 Financials
 Healthcare/BioTech
 Industrials
 IT & Computers
 Materials
 Telecommunications
 Utilities
Search


Public Companies : Healthcare/BioTech


MediSys Corporation Engages Corporate Finance Team

Jun 27, 2008 - 3:36:01 PM

News Source MARKET WIRE

Email this article
 Printer friendly page
PALM BEACH GARDENS, FL -- (MARKET WIRE) -- 06/27/08 -- MediSys Corporation (PINKSHEETS: MDYO) today announced it has engaged GIC Management Services Corp. ("GIC")of Pompano Beach, Florida to advise the Company regarding its capitalraising efforts. GIC, incorporated in 2005, has an extensive network ofrelationships in the European financial community and specializes inassisting micro-cap companies privately place debt and equity securitieswith European institutional investors. The principals of GIC have procuredfunding for clients ranging from $500,000 to $6,000,000 and during the last3 years have assisted companies in raising approximately $25,000,000. Inaddition, the principals of GIC have been involved in mergers andacquisitions of public entities traded on NASDAQ, AMEX, OTCBB and the PinkSheets. The Company is seeking to raise the capital required to implementits business strategy.

Joshua Konigsberg, CEO of MediSys Corporation, was quoted as saying, "Onbehalf of the MediSys team, we are thrilled to have GIC Management join us.We believe they have the expertise and relationships to be successful inprocuring the funding for execution of our new business strategy."

About MediSys

MediSys Corporation provides medical diagnostic solutions to physicians inthe internal medicine, family medicine and general practice markets. TheCompany's innovative clinical programs are easily integrated into thephysicians practice, are cost-effective and enhance patient care. Theseprograms or "systems" enable doctors to provide superior medicaldiagnostics & treatment while significantly improving their revenues andprofits.

Disclaimer Regarding Forward-Looking Statements:

This announcement may contain certain forward-looking statements that aremade pursuant to the "safe harbor" provisions of the Private SecuritiesLitigation Reform Act of 1995 that involve risks and uncertainties. Suchstatements reflect management's current views and are based on certainassumptions. Actual results could differ materially from the assumptionscurrently anticipated. Forward-looking statements speak only as of the datethe statement was made. The Company assumes no obligation to updateforward-looking information to reflect actual results, changes inassumptions or changes in other factors affecting forward-lookinginformation. If the Company does update any forward-looking statement, noinference should be drawn that the Company will make additional updateswith respect to that statement or any other forward-looking statements.

Contact:
Brian Gibson
800 Village Square Crossing
Suite 323
Palm Beach Gardens, FL 33410
Tel: 561-622-5889
Fax: 561-537-7188
e-mail: Email Contact
www.medisyscorp.com



Top of Page | Main News Index | EmpireRelations.com Home Page EmpireRelations.com Selected Clients News

Come see our services. Copr. © 2005 Empire Relations Group, Inc.

Healthcare/BioTech
Latest Headlines
CLX Medical, Inc. Issues August 2008 Newsletter Highlighting Planned Acquisition of the ThyroTest(R) Rapid Screening Device
New Director of Operations Announced at MIHS
SinoFresh(R) Nasal Spray Kills MRSA "Super-Bug" in Live Noses
Smith & Nephew Plc - Transaction in Own Shares
Oncologix Announces Signing of Asset Purchase Agreement Pertaining to Selling Its Oncosphere Assets
Clinical Studies Completed for HeartVue's 6S Heart Screening System
Trimedyne Enters Into Letter of Intent With FemSuite, LLC
Forbes Medi-Tech Announces Sale of Pharmaceutical Assets
Stellar Pharmaceuticals Inc. Announces Successful Completion of Watson's Pilot Clinical Study
MethylGene Provides Update on Suspension of New Enrollment in MGCD0103 Clinical Trials